N/A
N=524
Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT02582957 ↗Enrolled (actual)
524
Serious AEs
41.7%
Results posted
Jun 2024
Primary outcome: Primary: Ventilator-free Days (VFDs) — 18.4; 16.1 days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Sigh breaths (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Minnesota
- Primary completion
- Oct 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ventilator-free Days (VFDs) |
18.4; 16.1 | — |
| SECONDARY All-cause Mortality |
30; 46 | — |
| SECONDARY ICU-free Days |
13.7; 11.9 | — |
| SECONDARY Number of Participants With Complications of Treatment |
18; 20; 57; 69; 127; 120 | — |
| SECONDARY Discharge Status |
6; 5 | — |
| SECONDARY Number of Participants Requiring Oxygen Therapy at Discharge |
20; 12 | — |
Summary
A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.
Eligibility Criteria
Inclusion Criteria
Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation who also have one or more of the following:
- Traumatic brain injury
- > 1 long bone fractures
- Shock on arrival in the Emergency Department (systolic BP 6 units of blood
Exclusion Criteria
- Inability to obtain consent from the patient or his/her legally authorized representative (LAR)
- Unwillingness of the treating physician to use sigh ventilation as all treating physicians must have equipoise with respect to the intervention
- Age limitations per Institutional Review Board regulations
- Undergoing invasive mechanical ventilation for > 24 hours, excluding any time during which the patient was being ventilated in the operating room, CT or IR, as this could represent too long a delay in instituting the intervention for it to have a chance of being effective
- Presence of malignancy or other irreversible disease or condition for which the six month mortality is estimated to exceed 50% (e.g., chronic liver disease with a Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect the clinical course and cloud interpretation of the endpoints
- Women who are pregnant (negative pregnancy tests required on women of child-bearing age) per Human Subjects regulations
- Prisoners, per Human Subjects regulations
- Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher spinal cord injury as this could affect the clinical course and cloud interpretation of the ventilator-free day endpoint
- Lack of availability of Dräger Evita Infinity V500 ventilator as this is the only ventilator capable of delivering sigh breaths as described in the protocol
- Burns > 40% of body surface area as this could affect the clinical course and cloud interpretation of the endpoints
- Treating physicians being unwilling to use low VT ventilation strategy when ARDS is diagnosed as low VT ventilation is now considered standard of care for patients with ARDS.
- Moribund, not expected to survive 24 hours as this could affect the clinical course and cloud interpretation of the endpoints13. Treating physician's decision to use airway pressure release ventilation (APRV).
- Patient not expected to require mechanical ventilation > 24 hours (e.g., intubated for alcohol intoxication rather than pulmonary problem).
Data sourced from ClinicalTrials.gov (NCT02582957). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.